Toevolution

The global generic sterile injectables market in 2020 is estimated for more than US$ 434.7 Bn and expected to reach a value of US$ 930.3 Bn by 2028 with a significant CAGR of 10.0%.

The biologics market is estimated to reach at a value of US 339.3 Bn by the end of 2022 and expected to reach at a value of US$ 610.2 Bn by 2030 with a significant CAGR of 7.6%.

The current valuation of the Peptide Cancer Vaccine Market is USD 4.72 Billion in 2022. The market value of the Peptide Cancer Vaccine market is anticipated to reach a high of USD 10.07 Billion by the year 2028. A historical CAGR of 11.20% has been...